DAEHAN NEW PHARM CO., LTD. financial statements, including revenue, expenses, profit, and loss
The total revenue of 054670 for the last quarter is 48.81 B KRW, and it's 9.84% lower compared to the previous quarter. The net income of Q3 24 is 1.97 B KRW.